GSK Australia Media Release Increasing investment in adult immunisation has the potential to deliver $1.1 billion in benefits every year, according to a new report commissioned by GSK, examining the opportunity to increase access to vaccination and disease prevention.1 Prevention: A Productivity Superpower was launched by GSK Australia at Parliament House, Canberra today and demonstrates…
The post New report: Investment in adult vaccination can deliver a $1.1bn net annual return appeared first on The AIM Network.